• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Low-care Value Not Associated With Healthcare Experience Ratings, Study Finds

Article

Results suggest that providers won’t be penalized in patient experience scores if they say no to ordering unnecessary tests and procedures such as a PSA test for an older men or head imaging for a patient with uncomplicated headache.

Some research suggests that physicians may provide unnecessary or marginally useful services because patients want the services and physicians cater to their wishes. But results reported this week in JAMA Internal Medicinepoke a hole in that theory. A research team led by Prachi Sanghavi, Ph.D., of The University of Chicago did not find an association between “low-value” care and higher ratings on a standard survey used to assess patient experience.

Sanghavi and her colleagues said their findings may reduce the use of low-value care to appease patient and alleviate concerns that the patient experience and satisfaction scores used in value-based care could be counterproductive.

Sanghavi conducted their study by sifting through Medicare fee for service for eight low-value service, such PSA tests for older men, cervical cancer screening for older women, head imaging for uncomplicated headache. They used that data to create composite measure of exposure to low-value care.

For patient experience, they used results from the Consumer Assessment of Healthcare Providers and System (CAHPS) Medicare fee-for-service survey. That survey asks questions about interactions with physicians, such as whether the physician listened carefully to the patient and explained things clearly, as well as about timely access to care and overall rating of the healthcare services the patient has received.

They assessed the association between “exposure” to low-value care and CAHPS results for 100,743 primary care professional (PCP) patient panels that had, on average, 258 patients per panel. For the most part, their analysis did not find a statistical link between exposure to low-value care and a better health experience as measured by CAHPS. But the study also did not find an association between low-value care and a worse health experience as measured by CAPHS, with one exception: long waiting room times were associated with exposure to low-value care. One possible explanation offered by Sanghavi and her colleagues is that “poorly organized or overwhelmed practices substitute wasteful services for higher-value services that require more cognitive effort and clinician time.”

“We did not find evidence that patients who are exposed to more low-value care rate their health care experiences better,” they concluded. “They also generally do not rate their healthcare worse, which may because they are unable to assess the value of care or because their physicians effectively correct information asymmetries through shared-decision making when denying low-value services.”

Related Videos
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Video 5 - "Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics"
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Video 1 - "Overview of Prescription Digital Therapeutics and Impact on Clinical Practice"
Video 4 - "Payer Challenges in Evaluating Digital Therapeutics"
Video 3 - "Industry Collaboration in Shaping Digital Therapeutics Standards"
Video 6 - "Key Takeaways and Unmet Needs in Diabetes Treatment"
Video 5 - "Allocation of Investment and Value-Based Arrangements in Diabetes Care "
Related Content
© 2024 MJH Life Sciences

All rights reserved.